Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
SCHAUMBURG, Ill., Jan 7 (Bernama-BUSINESS WIRE) — Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today provided an update on recent business highlights and financial performance for 2024 and strategic priorities for 2025 ahead of the Company’s participation in the 43rd Annual J.P. Morgan Healthcare Conference from…

